“That means of the $141 million they spent on this drug in 2022, $133 million of it was wasted”

Pharmaceutical companies skyrocket the price of prescriptions to Medicare because taxpayers are paying for it

By News on the Net -- Wall Street Apes——Bio and Archives--March 21, 2025

News in Brief—News Headlines | CFP Comments | Subscribe | Email Us

This is the worst one yet. Pharmaceutical companies skyrocket the price of prescriptions to Medicare because taxpayers are paying for it

- Drug Tetrabenazine, Medicare pays $2,600 per prescription
- Regular price $75
- Medicare is paying 34X THE PRICE PER PRESCRIPTION
-… pic.twitter.com/vRd3cwmBcB
— Wall Street Apes (@WallStreetApes)March 21, 2025

View Comments

News on the Net——Bio and Archives

News from around the world